-
An exercise designed to test laboratory readiness for a bioterrorism incident turned into a real-life disaster of another sort when specimen mislabeling and flagrant breaches in infection control resulted in numerous exposures to an attenuated vaccine strain of Brucella abortus RB51, the Centers for Disease Control and Prevention reports.
-
As the number of high-containment labs undergoes an unprecedented expansion in the United States, the question of relative risk is coming to the forefront.
-
A rapid, ongoing expansion in the number of high-containment biodefense laboratories throughout the nation is raising serious questions about the safety of lab workers, the risk to the public, and the lack of government oversight to prevent accidents and security breaches.
-
Americans use many medications for countless medical conditions, spending about $100 billion annually. Unfortunately, partly because we use so many medications, medication error has become an important medical topic in the 21st century.
-
-
Federal and state funding for family planning client services reached $1.85 billion in FY 2006, a 63% increase over 12 years, adjusting for inflation.
-
A multidrug-resistant variant of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteria is emerging in cities on both coasts of the United States, according to data from a new California-led study.
-
Patients seeking medication abortion using mifepristone (Mifeprex, Danco Group) may be asking questions after news agencies reported leukemia drug safety issues at a Chinese drug manufacturing firm that serves as the sole U.S. supplier of mifepristone.
-
Results of a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) indicate that most of the 1,000 women polled often confused myth with fact when quizzed about cervical cancer prevention.
-
Good news for your patients who use oral contraceptives (OCs): A new analysis of 45 epidemiological studies shows that use of such pills during a woman's lifetime gives substantial long-term protection against ovarian cancer.
